Table 5. Treatment-related adverse events occurring in at least 10% of patients (n=32).

Adverse events	No. grade 1/2 [%]	No. grade 3 [%]	Total No. [%]
Changes in hair color	22 [69]	0 [0]	22 [69]
Diarrhea	15 [47]	5 [16]	20 [63]
Hypertension	11 [34]	5 [16]	16 [50]
Fatigue	14 [44]	1 [3]	15 [47]
Nausea	13 [41]	0 [0]	13 [41]
Hand-foot syndrome	7 [22]	5 [16]	12 [38]
Stomatitis	12 [38]	0 [0]	12 [38]
Increased ALT	7 [22]	4 [12]	11 [34]
Increased AST	7 [22]	3 [9]	10 [31]
Alopecia	9 [28]	0 [0]	9 [28]
Vomit	8 [25]	1 [3]	9 [28]
Abdominal pain	8 [25]	0 [0]	8 [25]
Neutrocytopenia	5 [16]	2 [6]	7 [22]
Rash	5 [16]	1 [3]	6 [19]
Proteinuria	3 [10]	3 [10]	6 [19]
hypothyroidism	5 [16]	0 [0]	5 [16]
Hemoglobin decreased	4 [13]	0 [0]	4 [13]

ALT, alanine aminotransferase; AST, aspartate aminotransferase.